We narrowed to 203 results for: HGF
- 
  Plasmid#76060Purpose3rd generation lentiviral gRNA plasmid targeting human METDepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  MET gRNA (BRDN0001147542)Plasmid#76062Purpose3rd generation lentiviral gRNA plasmid targeting human METDepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  MET gRNA (BRDN0001147560)Plasmid#76061Purpose3rd generation lentiviral gRNA plasmid targeting human METDepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  MST1 gRNA (BRDN0001147042)Plasmid#75777Purpose3rd generation lentiviral gRNA plasmid targeting human MST1DepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  MST1 gRNA (BRDN0001146525)Plasmid#75776Purpose3rd generation lentiviral gRNA plasmid targeting human MST1DepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  MST1 gRNA (BRDN0001148968)Plasmid#75778Purpose3rd generation lentiviral gRNA plasmid targeting human MST1DepositorAvailable SinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only
- 
  pHAGE-METPlasmid#116762PurposeLentiviral expression of METDepositorAvailable SinceMarch 14, 2019AvailabilityAcademic Institutions and Nonprofits only
- 
  pDONR223_MET_WTPlasmid#82307PurposeGateway Donor vector containing MET , part of the Target Accelerator Plasmid Collection.DepositorAvailable SinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits only
- 
  sgMST1/2-2Plasmid#229430Purposeknockout of MST1 and MST2DepositorUseCRISPR and LentiviralExpressionMammalianPromoterhU6;bU6;EFSAvailable SinceDec. 18, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  sgMST1/2-1Plasmid#229429Purposeknockout of MST1 and MST2DepositorUseCRISPR and LentiviralExpressionMammalianPromoterhU6;bU6;EFSAvailable SinceDec. 18, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pDONR223-METPlasmid#23889DepositorInsertMET (MET Human)
 UseGateway donor vectorAvailable SinceJuly 30, 2010AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A12.T)Viral Prep#157970-AAV.A12.TPurposeReady-to-use AAV44.9(E531D) in PBS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A01.T)Viral Prep#157970-AAV.A01.TPurposeReady-to-use AAV2 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A09.T)Viral Prep#157970-AAV.A09.TPurposeReady-to-use AAV6 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A11.T)Viral Prep#157970-AAV.A11.TPurposeReady-to-use AAV44.9 in PBS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A10.T)Viral Prep#157970-AAV.A10.TPurposeReady-to-use AAV6(dbY-F+T-V) in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A07.T)Viral Prep#157970-AAV.A07.TPurposeReady-to-use AAV2 (trpYF) in BSS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A06.T)Viral Prep#157970-AAV.A06.TPurposeReady-to-use AAV2 (trpYF) in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A04.T)Viral Prep#157970-AAV.A04.TPurposeReady-to-use AAV2 (Y444F) in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
- 
  pTR-UF11 (AAV.A05.T)Viral Prep#157970-AAV.A05.TPurposeReady-to-use AAV2 (Y444F) in BSS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoterDepositorPromoterchimeric CMV/Chicken Beta actin (CBA)TagsGFPAvailable SinceDec. 21, 2020AvailabilityAcademic Institutions and Nonprofits only
 
       
       
       
       
       
       
       
       
       
      